EMA — authorised 31 December 2009
- Application: EMEA/H/C/001020
- Marketing authorisation holder: Axxonis Pharma AG
- Local brand name: Nenad
- Status: withdrawn
EMA authorised Lisurid on 31 December 2009
Yes. EMA authorised it on 31 December 2009.
Axxonis Pharma AG holds the EU marketing authorisation.